Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
BMC Endocrine Disorders|August 10, 2023
Unmasked insulinoma occasioned by severe hypoglycemic coma immediately postpartum: a case reportKiyoshi Matsumoto, Miyu Watanabe, Ken Takao, et al.
Diabetology International|January 21, 2022
Hypoglycemic coma in an elderly adult switched from twice-daily vildagliptin to once-daily glimepiride to improve drug adherenceShunsuke Tominari, Megumi Yasuda, Takehiro Kato, et al.
The Journal of Endocrinology|January 9, 2026
ChREBP Deficiency Aggravates Diabetic Sarcopenia by Disrupting Glucose Signaling: A Novel Mouse Model of Muscle AtrophyToshinori Imaizumi, Katsumi Iizuka, Hiromi Tsuchida, et al.
Frontiers in Clinical Diabetes and Healthcare|July 31, 2025
Predicting diabetic retinopathy stages using a simple nerve conduction measuring device, DPNCheck®: a retrospective observational studyMayu Sakai, Takehiro Kato, Takuma Ishihara, et al.
Diabetology International|October 29, 2024
Hypovascular insulinoma with reduced microvessel density on histopathology: a case reportRisako Imai, Mayu Sakai, Takehiro Kato, et al.
Journal of Diabetes Investigation|October 25, 2022
Association of dipeptidyl peptidase-4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in JapanSodai Kubota, Takuya Haraguchi, Hitoshi Kuwata, et al.
Journal of Diabetes Investigation|March 15, 2021
A novel RFX6 heterozygous mutation (p.R652X) in maturity-onset diabetes mellitus: A case reportSakiho Imaki, Katsumi Iizuka, Yukio Horikawa, et al.
The Journal of Endocrinology|February 4, 2021
Effects of ChREBP deficiency on adrenal lipogenesis and steroidogenesisKen Takao, Katsumi Iizuka, Yanyan Liu, et al.
Journal of Diabetes Investigation|February 3, 2026
Endogenous GIP signaling is indispensable for DPP-4 inhibitor-mediated metabolic control in miceSaki Kubota-Okamoto, Sodai Kubota, Hiromi Tsuchida, et al.
Pageof 8